- Home
- RNTX vs GTEC Comparison
RNTX vs GTEC Comparison
Compare RNTX & GTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNTX
- GTEC
- Stock Information
- Founded
- RNTX 2001
- GTEC 2006
- Country
- RNTX United States
- GTEC United States
- Employees
- RNTX N/A
- GTEC N/A
- Industry
- RNTX Biotechnology: Pharmaceutical Preparations
- GTEC Industrial Machinery/Components
- Sector
- RNTX Health Care
- GTEC Industrials
- Exchange
- RNTX Nasdaq
- GTEC Nasdaq
- Market Cap
- RNTX 40.3M
- GTEC 35.8M
- IPO Year
- RNTX N/A
- GTEC N/A
- Fundamental
- Price
- RNTX $1.16
- GTEC $1.62
- Analyst Decision
- RNTX
- GTEC
- Analyst Count
- RNTX 0
- GTEC 0
- Target Price
- RNTX N/A
- GTEC N/A
- AVG Volume (30 Days)
- RNTX 56.1K
- GTEC 118.6K
- Earning Date
- RNTX 08-13-2025
- GTEC 08-18-2025
- Dividend Yield
- RNTX N/A
- GTEC N/A
- EPS Growth
- RNTX N/A
- GTEC N/A
- EPS
- RNTX N/A
- GTEC 1.14
- Revenue
- RNTX N/A
- GTEC $82,898,634.00
- Revenue This Year
- RNTX N/A
- GTEC $3.28
- Revenue Next Year
- RNTX N/A
- GTEC N/A
- P/E Ratio
- RNTX N/A
- GTEC $1.38
- Revenue Growth
- RNTX N/A
- GTEC N/A
- 52 Week Low
- RNTX $1.04
- GTEC $1.17
- 52 Week High
- RNTX $4.40
- GTEC $2.94
- Technical
- Relative Strength Index (RSI)
- RNTX N/A
- GTEC 34.03
- Support Level
- RNTX N/A
- GTEC $1.51
- Resistance Level
- RNTX N/A
- GTEC $1.66
- Average True Range (ATR)
- RNTX 0.00
- GTEC 0.10
- MACD
- RNTX 0.00
- GTEC -0.02
- Stochastic Oscillator
- RNTX 0.00
- GTEC 20.00
About RNTX Rein Therapeutics Inc. Common Stock
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.